Investigational Drug Information for Camptothecin
✉ Email this page to a colleague
What is the drug development status for Camptothecin?
Camptothecin is an investigational drug.
There have been 154 clinical trials for Camptothecin.
The most recent clinical trial was a Phase 3 trial, which was initiated on September 14th 2009.
The most common disease conditions in clinical trials are Neoplasms, Adenocarcinoma, and Lung Neoplasms. The leading clinical trial sponsors are National Cancer Institute (NCI), Astex Pharmaceuticals, Inc., and Astex Pharmaceuticals.
Summary for Camptothecin
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 4,768 |
| WIPO Patent Applications | 2,418 |
| Japanese Patent Applications | 128 |
| Clinical Trial Progress | Phase 3 (2009-09-14) |
| Vendors | 65 |
Recent Clinical Trials for Camptothecin
| Title | Sponsor | Phase |
|---|---|---|
| 64Cu/68Ga Labelled EB-ss-CPT PET/CT Scan in Colorectal Cancer | Peking Union Medical College Hospital | Early Phase 1 |
| A Trial of NIS793 With FOLFIRINOX in Pancreatic Cancer | Novartis | Phase 2 |
| A Trial of NIS793 With FOLFIRINOX in Pancreatic Cancer | Kimberly Perez | Phase 2 |
Clinical Trial Summary for Camptothecin
Top disease conditions for Camptothecin
Top clinical trial sponsors for Camptothecin
US Patents for Camptothecin
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
